|
HS Code |
950587 |
| Generic Name | Fentanyl Citrate |
| Brand Names | Sublimaze, Actiq, Duragesic (patch form) |
| Drug Class | Opioid analgesic |
| Chemical Formula | C22H28N2O·C6H8O7 |
| Route Of Administration | Intravenous, intramuscular, transdermal, buccal, sublingual |
| Indications | Severe pain, anesthesia adjunct |
| Mechanism Of Action | Mu-opioid receptor agonist |
| Controlled Status | Schedule II (Controlled Substance) |
| Onset Of Action | Immediate to a few minutes (IV) |
| Duration Of Action | 30–60 minutes (IV) |
| Metabolism | Primarily hepatic (CYP3A4) |
| Half Life | 3–12 hours |
| Side Effects | Respiratory depression, nausea, constipation, sedation |
| Contraindications | Known hypersensitivity, significant respiratory depression |
| Storage Conditions | Store below 25°C (77°F), protect from light |
As an accredited Fentanyl Citrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sterile clear glass vial labeled "Fentanyl Citrate Injection, 100 mcg/2 mL (50 mcg/mL)," sealed with gray rubber stopper. |
| Shipping | Fentanyl Citrate must be shipped according to strict regulations as a controlled substance. It requires secure, tamper-evident packaging and clear labeling. Shipments must be accompanied by appropriate documentation, handled only by authorized personnel, and transported in compliance with federal, state, and international laws to ensure safety and prevent diversion. |
| Storage | Fentanyl Citrate should be stored in a tightly closed container at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Store in a secure, locked location, as fentanyl citrate is a potent opioid and a controlled substance. Keep out of reach of unauthorized individuals, children, and pets to prevent misuse or accidental exposure. |
|
Purity 99.5%: Fentanyl Citrate Purity 99.5% is used in surgical anesthesia induction, where rapid onset of analgesia is achieved with minimized impurities. Sterile injectable grade: Fentanyl Citrate Sterile injectable grade is used in intravenous pain management for intensive care units, where consistent drug bioavailability ensures predictable patient response. Particle size <10 microns: Fentanyl Citrate Particle size <10 microns is used in transdermal patch manufacturing, where uniform dispersion allows for sustained and controlled drug release. Melting point 189°C: Fentanyl Citrate Melting point 189°C is used in pharmaceutical compounding, where thermal stability maintains compound integrity during formulation processes. Stability temperature 25°C: Fentanyl Citrate Stability temperature 25°C is used in clinical storage environments, where chemical potency is preserved under standard conditions. Water solubility 50 mg/mL: Fentanyl Citrate Water solubility 50 mg/mL is used in oral transmucosal delivery systems, where rapid dissolution increases therapeutic efficiency. Endotoxin level <0.25 EU/mg: Fentanyl Citrate Endotoxin level <0.25 EU/mg is used in epidural administration, where low endotoxin content minimizes risk of pyrogenic reactions. USP grade: Fentanyl Citrate USP grade is used in compounding pharmacies, where adherence to pharmacopeial standards ensures consistent quality for patient-specific formulations. Assay ≥99%: Fentanyl Citrate Assay ≥99% is used in injectable opioid preparations, where precise dosing accuracy enhances patient safety and efficacy. Residual solvent <50 ppm: Fentanyl Citrate Residual solvent <50 ppm is used in hospital compounding, where minimized solvent content reduces potential toxicity risks. |
Competitive Fentanyl Citrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into any hospital, one will notice that pain control plays a cornerstone role in healing. Fentanyl Citrate, better known to doctors and nurses on the floor as a reliable, fast-acting pain reliever, stands out because it delivers relief when other options fall short. It’s clear why this matters. Surgeries, emergency procedures, and cancer treatments bring intense pain. For many patients, Fentanyl Citrate becomes the only avenue to keep that agony under control.
Unlike morphine or hydromorphone, Fentanyl Citrate shows its power at incredibly low doses. Its potency doesn’t just mean a stronger medication; it means rapid relief with smaller volumes, a trait essential in tight clinical timelines. The science behind this centers on how fentanyl interacts with the body. It binds to opioid receptors in the brain but crosses the blood-brain barrier faster than almost any comparable painkiller. The result: meaningful effects within minutes.
I’ve seen in practice how this property makes all the difference, especially for patients who can’t tolerate large fluid volumes, such as those suffering from heart failure or kidney disease. Fentanyl’s strength means doctors inject or infuse smaller amounts, reducing stress on overloaded bodies. In an environment where every second counts and every drop matters, there is practical value in having a tool this precise.
Fentanyl Citrate shows up in multiple forms—intravenous solutions, lozenges, and patches. Most hospitals stock IV vials of 100 micrograms per 2 ml, although those who deal with children, burn patients, or critical care situations often reach for more dilute or more concentrated formulations. This shift in preparation makes it practical for a variety of patients and settings.
The flexibility in administration isn’t just a technical perk. Some patients need their pain tackled fast and hard, like those waking up from surgery or caught in the throes of a sickle-cell crisis. Others need slow, steady coverage, using patches or lozenges for continuous comfort. Back in my early days in the ICU, watching a patient come out of anesthesia comfortably—with eyes clear, breathing steadily—highlighted for me the unique window Fentanyl Citrate opens, especially among people sensitive to blood pressure drops or asthma attacks. Its impact is not just clinical, but deeply personal for those who need it most.
With all its strengths, Fentanyl Citrate brings a heavy responsibility. Its potency comes with risk. The difference between helpful and harmful doses is razor-thin. In the wrong circumstances, respiratory depression becomes a genuine threat. Public health faces a real struggle because of mismanaged fentanyl—both in healthcare settings and on the street. Hospitals have clear protocols in place: locked storage, two-person verification, and tight record-keeping for every milligram that changes hands.
Education helps safeguard everyone involved. Training encourages teams to titrate doses patiently, understand patient histories, and act quickly if someone shows signs of overdose: shallow breathing, pinpoint pupils, unresponsiveness. Tools like naloxone—an opioid reversal drug—sit close at hand on crash carts, and seasoned clinicians quietly double-check their math before every push or drip, knowing the stakes couldn’t be higher.
Society at large faces a linked challenge. Fentanyl analogues, manufactured illicitly, flood streets in waves few predicted. It surprises me how much this pharmaceutical innovation—first developed for real, urgent patient pain—has turned into a public health threat. The fentanyl used in medical practice shares little in common with street mixes, often laced with unpredictable additives and unmonitored doses. One batch can knock back pain in an operating room, another can take a life in minutes outside the hospital. Experts point out, and my experience supports, that awareness, careful stewardship, and strong oversight make all the difference in tilting this balance toward benefit rather than harm.
Fentanyl Citrate’s closest rivals include morphine, hydromorphone, and oxycodone. The differences between them go deeper than just strength. Morphine has been the workhorse for centuries, but in real life, it often drops blood pressure, especially in patients already on the edge. Hydromorphone packs a punch, but its slower onset can make it hard to control pain that spikes quickly. Oxycodone comes in pills or liquid, but can’t answer those moments requiring near-instant action.
Fentanyl’s quick onset means doctors rely on it in settings where pain ebbs and flows fast. It gets used in short surgical procedures, in the emergency room during major trauma, or as “breakthrough” pain relief for cancer patients already on regular narcotics. In my time assisting at bedside, I noticed that patients hooked up to ventilators or those in shock respond in ways subtle but significant; fentanyl helps relieve pain without the deep sedation or low blood pressure that morphine sometimes brings.
One vivid memory involves talking with a nurse caring for a child recovering from severe burns. Morphine did not manage the pain, leading to distress every time the dressings needed changing. Fentanyl, given in tiny careful doses, offered comfort and a chance for healing without the same risk of unstable blood pressure or ongoing grogginess. Differences like this shape more than protocol—they shape the outcome for real people in challenging moments.
Behind every sterile vial sits a story. Over the years, conversations with patients and families widened my understanding. People living with metastatic cancer count the days when pain seizes them without warning. They search not just for relief, but also a chance to remain present with loved ones. Fentanyl Citrate, dissolved in a lollipop or absorbed through a patch, became their bridge back to a life that pain tried to steal.
Emergency medical workers face high-pressure moments where they must relieve suffering on the fly. Picture a paramedic kneeling by the roadside, balancing dosages in the chaos of trauma. Fast-absorbing fentanyl answers the call with no delay—patients regain some control, anxiety falls, and precious minutes tick by more gently before hospital doors swing open. In those moments, there are few substitutes.
I remember a postoperative patient, wracked with pain and fearful of addiction. Explaining the tight guardrails around hospital-administered fentanyl reassured him and his family. We talked about side effects, the need for follow-up, and how we’d switch to safer oral alternatives as soon as possible. This transparency matters because trust lets people focus on healing—not on worrying about what’s going into their veins.
Misunderstanding drives much of the fear and stigma around opioids like Fentanyl Citrate. People worry about addiction, overdose, and whether any use at all opens the door to misuse. These concerns are real, but context matters. A single dose after surgery is not the same as chronic high-dose use, and doctors weigh many factors before prescribing. These include prior history, drug interactions, and close observation.
Even with precise protocols, things go wrong sometimes. Early in my career, I saw a patient develop slow breathing after a pain medication mix-up. Staff reacted quickly, reversing the effects with naloxone, and re-educating themselves to prevent a repeat. Such experiences highlight why awareness and humility—among every member of a medical team—are part of safe opioid prescribing.
Legislation aims to prevent diversion, requiring strict record-keeping, electronic logs, and monitoring systems that track prescriptions. Hospitals review dosages and complications routinely, always pushing to catch errors before harm occurs. Open communication helps—patients and families ask questions, voice concerns, and draw on up-to-date information from pharmacists, nurses, and doctors. Education, at every step, discourages misuse and misunderstanding.
Fentanyl Citrate shows the amazing progress possible in medicine—a substance born to end suffering, delivered in doses a fraction the size of those needed with older painkillers. Still, it sits at the intersection of genuine care and serious risk. Calls for blanket bans echo in news headlines, driven by stories of overdose and tragedy. On the hospital floor, though, the reality is less black-and-white. Denying access leaves many patients in agony. Over-prescribing or careless management brings real danger.
Teams in healthcare weigh these risks every day. Regular review meetings sift through cases, looking for patterns and problem areas. New guidelines recommend shifting from routine, high-dose opioids to the smallest effective dose for the shortest time possible. Pairing painkillers with physical therapy, counseling, and non-drug alternatives helps treat the whole person, not just their pain.
Patients gain most when supported by honest discussions. Those who need Fentanyl Citrate temporarily learn about tapering schedules, side effects to watch for, and how to store or return leftover medication safely. Support groups and online forums let people share experiences, reducing isolation and fear. It’s about creating a safety net that includes everyone—clinicians, patients, regulators, and the community at large.
The debate over fentanyl isn’t just about policy. Ongoing research changes how clinicians use it. Studies explore its effect on different ages, ethnicities, and those with chronic conditions. Scientists dig into genetic differences that affect how quickly fentanyl acts or how long it lingers in the body. This matters for real-world dosing and for preventing unexpected reactions.
Hospitals keep up by holding training sessions and simulation drills. Young residents practice administering pain relief under close watch. Veterans share stories where pain management didn’t go as planned—mistakes are learning moments, not just reasons for blame. Frequent updates make clear: the science moves fast, and so should the training.
Community education campaigns—especially around opioid risk—help the public separate medical fact from urban myth. School programs, neighborhood events, and credible online sources all have a role. I’ve noticed in my own circles that stigma drops when people learn what fentanyl is meant for, how it’s used, and what warning signs matter most. Being informed beats being scared or skeptical.
Innovation hasn’t stopped with Fentanyl Citrate’s arrival. Researchers keep searching for new pain control tools that carry less risk. That includes non-opioid medications, nerve-block devices, and digital software tracking pain alongside activity and mood. Still, nothing has replaced fentanyl for high-stress, high-urgency cases. The focus for now lands on improving safety: better labeling, tamper-resistant packaging, smart infusion pumps that alert staff to dangerous dosing, and apps that warn clinicians of worrisome drug combinations.
Teamwork carries the process forward. Pharmacists keep inventories tight, nurses verify every dose, and doctors rethink plans for people at higher risk. I’ve seen big improvements where all parts of the team—right down to hospital IT staff building smarter monitoring platforms—commit to the same goal: pain relief without running headlong into disaster.
One of the more interesting ideas I’ve seen involves patient participation. New programs let patients log their own pain levels, side effects, and questions in real time. That feedback shapes future use, provides early warning of problems, and build trust between caregivers and families. Moving forward, this blend of technology and trust will decide how Fentanyl Citrate fits into care—both in high-drama emergencies and steady long-term cases.
For those of us who have worked alongside Fentanyl Citrate, its impact stretches past numbers or chemical formulas. It’s about giving people control, easing suffering, and sometimes easing fear in moments when life grows unpredictable. The differences between medications matter because the people using them come with unique stories—stories that deserve not just medicine, but understanding, humility, and partnership.
By keeping education, research, and honest conversation in the foreground, health systems give Fentanyl Citrate a place where it heals, not harms. The sharp edge dividing medical necessity from misuse will always demand attention, but experience and science together offer a path forward. The voices of patients, families, and clinicians all deserve a seat at the table as the story continues to unfold.